Keyphrases
Abnormal Uterine Bleeding
75%
Iron Deficiency Anemia
50%
Ulipristal Acetate
50%
Self-scoring
50%
Hirsutism
50%
Fibroids
50%
Laparoscopy
50%
During Pregnancy
50%
Laparoscopic Management
50%
Intravenous Iron Therapy
50%
Polycystic Ovary Syndrome
50%
Intravenous Iron
50%
Severe Anemia
29%
Indications for Treatment
25%
Iron Loss
25%
Anemia
25%
Selective Progesterone Receptor Modulator
16%
Hysterectomy
16%
Normal Uterus
16%
Bleeding Control
16%
Acute Uterine Bleeding
16%
Childbearing Women
16%
Minimally Invasive Therapy
16%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
16%
Need for Surgery
16%
Highly Effective
16%
Restrospective
12%
Iron Recovery
12%
Menorrhagia
12%
Fertile Age
12%
Modified Ferriman-Gallwey
12%
Hemi-uterus
12%
Intervention Complexity
12%
Trocar Placement
12%
Uterine Size
12%
Reason for Consultation
12%
Copyright
12%
Acute Abdominal Pain
12%
Population Groups
12%
Hemoperitoneum
12%
Emergency Department
12%
Common Disease
12%
After Surgery
12%
Oral Treatment
12%
Fetus
12%
19th Century
12%
Healthy children
12%
Male Population
12%
Week of Gestation
12%
Surgeons
12%
Medicine and Dentistry
Menorrhagia
100%
Hirsutism
50%
Polycystic Ovary Syndrome
50%
Hypochromic Anemia
50%
Supplementation
50%
Clinician
50%
Anemia
50%
Ulipristal
50%
Laparoscopic Surgery
50%
Randomized Controlled Trial
50%
Hysteroscopy
50%
Iron
33%
Bleeding
29%
High-Risk Population
16%
Refractory Anemia
16%
Diseases
16%
Obstetrics
16%
Levonorgestrel
16%
Population
16%
Puerperium
16%
Fisher Exact Test
16%
Progesterone Receptor Modulator
16%
Hysterectomy
16%
Intrauterine Device
16%
Uterus Bleeding
16%
Side Effect
16%
Minimally Invasive Procedure
16%
Pregnancy
12%
Reproductive Medicine
12%
Consultation
12%
Testosterone
12%
Surgical Risk
12%
Hemoperitoneum
12%
Blood Stasis
12%
Supine Position
12%
Cesarean Section
12%
Acute Abdomen
12%
Vascular Network
12%
Neonatal Infant
12%
Surgeon
12%
Emergency Department
12%
Gestational Age
12%
Operating Room
10%
Patient Characteristics
10%
Vaginal Delivery
10%
Visual Analog Scale
10%
Pharmacology, Toxicology and Pharmaceutical Science
Menorrhagia
100%
Ulipristal
50%
Anemia
50%
Iron Deficiency Anemia
50%
Iron
33%
Progesterone Receptor Modulator
16%
Refractory Anemia
16%
Disease
16%
Side Effect
16%
Bleeding
16%
Levonorgestrel
16%
Intrauterine Device
16%
Uterus Bleeding
16%
